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    The interest of many urologists in chem．otherapy of carcinonia of the prostate has gtadually arisen
in the treatment of intractable cases to the anti－androgen therapy． The author have tried testing
several anti－tumor agents using nude mice with tumors resulting from inocculation of 6ultured cells
EB 33 which had been derived ’frem human prostatic carcinoma tissue． The growth curve of the
tumors in the tested group usually cemposed of 5 animals was compared to that of the control group．
Three different kind of agents were tested． Twenty mg／kg／day of 5－fiuolouracil （5－FU）， 60 and 100
・mg／kg／day of Futraful， a masked compound of 5－1””U， and I O mg／kgfday of cyclophosphtirriide （CP）
were ．injected lntrcaperitoneaJly for 14 consecutive days． Vincristine （YCR） was given at the dose
Gf O．45皿9／kg／day 7 ti血es 6n6e per 3 days． CP showed the significant reduction of the tumor growth
with minimal decrease of the body weight and VCR did the comparable effect wfth a little severer
complication， but no significant changes were resulted in 5－FU or Fptrafu1， although this compound
had been reported as clinically effective． Three patients who had been refractory to the proceeding
hormone therapy were treated with ta combination of Futrafu1， CP and VCRI based upon the obtained
e？（perimental resultti一． Thc clinical result was evaluated as O－O， 0－A5 and 1－B3， respectively， according
to Karno虚skゾs criteria． The improvement 6f the mode of administration will be a further su bj ect・
    The radiation therapy has greatly progr．essed in recent years． ・ However，’ it has been documented
that over 7，00e rad of irradiation would be necessary for a complete remission of the prostatic cancer，
because of its low sensitivity to irradiation， ln order to rninimize the complications caused by such a
high dose radiation， the author have continued to study experimehtally and clinically in different
two ways， ile． a． combination of 5－FU with radiation and intra－Qperative圭rradiatibn・After being
proven synergic ’ 奄?the cell culturc worl〈’ and the nude mouse experimen’t， 6，000 rad was irradiated
to 3 stage C patients with adminigtration of Futtaful． AII but one have been well controlled． ． The
complications were血inimal．．The other 4．唐狽≠№?B and G patients up to date have．b???i士radiated
3，000 rad ori the average through 6Pen perineal approach， The ctinical result is to be satisfied， and
the t’窒奄≠?is being carried en．
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症例．投与期間副作用自覚症状 他覚所見      効果判定予後健ク）
1．76歳  11W


















































































一一 窒?р浮モ狽奄pn in size
－markedJy degenerated cancer cells
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